VDR and colitis: Interestingly, epithelial-specific human VDR transgenic mice are protected from developing colitis due to the preservation of the mucosal barrier and protection of IECs from apoptosis through blocking TNF-α-induced p65 binding to the κB site of the PUMA gene promoter [60].